FdaApplication
NDA 210661
Identifiers
- fda_app_no: NDA210661
Properties
| Property | Value |
|---|---|
| applicant_name | AVYXA HOLDINGS LLC |
| application_type | NDA |
| approval_date | 2024-06-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AXTLE | PEMETREXED DIPOTASSIUM | EQ 100MG BASE/VIAL | POWDER;INTRAVENOUS |
| AXTLE | PEMETREXED DIPOTASSIUM | EQ 500MG BASE/VIAL | POWDER;INTRAVENOUS |
2 products